Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-10-17

FDA Approved: MIRTAZAPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Mirtazapine (Remeron) generic product filed by Sun Pharmaceutical Industries, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remeron (Mirtazapine) (Mirtazapine)

Snippet

SUPPL AP for MIRTAZAPINE (MIRTAZAPINE)